Linlin Zhou

915 total citations
31 papers, 676 citations indexed

About

Linlin Zhou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Linlin Zhou has authored 31 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Linlin Zhou's work include Cancer Immunotherapy and Biomarkers (6 papers), RNA and protein synthesis mechanisms (5 papers) and RNA modifications and cancer (5 papers). Linlin Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), RNA and protein synthesis mechanisms (5 papers) and RNA modifications and cancer (5 papers). Linlin Zhou collaborates with scholars based in China, Taiwan and Hong Kong. Linlin Zhou's co-authors include Richard M. Saunders, Yvonne C. F. Su, Wanming Li, Cai‐Guang Yang, Daniel C. Thomas, Danny Yu, Wei He, Jia‐Yi Wei, Fang Jin and Yue Huang and has published in prestigious journals such as Nature Communications, Neuroscience and Green Chemistry.

In The Last Decade

Linlin Zhou

28 papers receiving 667 citations

Peers

Linlin Zhou
Yuxuan Lu China
Youjun Wu China
Karolina Bojkowska Switzerland
Mary C. Abraham United States
Yanping Zhang China
Johanna S. Rees United Kingdom
N. Manoj India
James L. Pipkin United States
Alexander N. Patananan United States
Jessica L. Counihan United States
Yuxuan Lu China
Linlin Zhou
Citations per year, relative to Linlin Zhou Linlin Zhou (= 1×) peers Yuxuan Lu

Countries citing papers authored by Linlin Zhou

Since Specialization
Citations

This map shows the geographic impact of Linlin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Zhou more than expected).

Fields of papers citing papers by Linlin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Zhou. The network helps show where Linlin Zhou may publish in the future.

Co-authorship network of co-authors of Linlin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Linlin Zhou. A scholar is included among the top collaborators of Linlin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlin Zhou. Linlin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Jiayu, Hongyu Wang, Qianggao Hu, et al.. (2025). FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE. Clinical and Experimental Medicine. 25(1). 320–320.
3.
Zhou, Linlin, Yinghui Zhang, Jiayu Zhang, et al.. (2025). Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer. Frontiers in Oncology. 15. 1484103–1484103. 1 indexed citations
4.
Chen, Ling, Ping Hou, Yang Wang, et al.. (2024). B7–H1 agonists suppress the PI3K/AKT/mtor pathway by degrading p110γ and independently induce cell death. Cancer Letters. 584. 216615–216615.
5.
Zhou, Linlin & Danny Yu. (2024). Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment. Pharmacological Research. 204. 107205–107205. 32 indexed citations
6.
7.
Zhou, Linlin, Yun Xue, Pengyu Wang, et al.. (2023). Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma. Nature Communications. 14(1). 7069–7069. 23 indexed citations
8.
Wang, Pengyu, Tao Zhang, Xinjing Wang, et al.. (2022). Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. Cell chemical biology. 29(9). 1396–1408.e8. 38 indexed citations
9.
Zhou, Linlin, et al.. (2022). Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance. International Immunopharmacology. 113(Pt A). 109372–109372. 6 indexed citations
10.
Zhou, Linlin, Hongjiao Xu, Yue Huang, & Cai‐Guang Yang. (2021). Targeting the RNA demethylase FTO for cancer therapy. RSC Chemical Biology. 2(5). 1352–1369. 41 indexed citations
11.
Zhou, Linlin, et al.. (2021). Concise synthesis ofN-phosphorylated amides through three-component reactions. Green Chemistry. 23(23). 9417–9421. 9 indexed citations
12.
Lai, Jinzhi, Ying Liu, Linlin Zhou, et al.. (2021). Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity. Frontiers in Oncology. 11. 690188–690188. 25 indexed citations
13.
Yu, Danny, Linlin Zhou, & Qiuyu Zhang. (2021). Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance. International Immunopharmacology. 94. 107473–107473. 2 indexed citations
14.
Zhou, Linlin, et al.. (2020). RNA Methylation m6A: A New Code and Drug Target?. Chinese Journal of Chemistry. 38(4). 420–421. 13 indexed citations
15.
Feng, Yiming, Pan Fang, Linlin Zhou, et al.. (2020). Consecutive and automatic detection of multi-gene mutations from colorectal cancer samples by coupling droplet array-based capillary electrophoresis and PCR-RFLP. Analytical and Bioanalytical Chemistry. 412(13). 3037–3049. 2 indexed citations
16.
Li, Wanming, et al.. (2019). An ssDNA aptamer selected by Cell-SELEX for the targeted imaging of poorly differentiated gastric cancer tissue. Talanta. 199. 634–642. 31 indexed citations
17.
Li, Wanming, Linlin Zhou, Min Zheng, & Fang Jin. (2018). Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX. Molecular Therapy — Nucleic Acids. 12. 707–717. 37 indexed citations
18.
Yang, Ce, Wenting Gao, Haiyan Wang, et al.. (2015). CRH knockout inhibits the murine innate immune responses in association with endoplasmic reticulum stress after thermal injury. Surgery. 158(1). 255–265. 4 indexed citations
19.
20.
Yang, Ce, Linlin Zhou, Haiyan Wang, et al.. (2011). The inhibitory effect of Zingiber corallinum Hance essential oil on drug-resistant bacteria and evaluation of its acute toxicity. Medical Science Monitor. 17(5). BR139–BR146. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuxuan Lu Breakdown of academic impact, for papers by Youjun Wu Breakdown of academic impact, for papers by Karolina Bojkowska Breakdown of academic impact, for papers by Mary C. Abraham Breakdown of academic impact, for papers by Yanping Zhang Breakdown of academic impact, for papers by Johanna S. Rees Breakdown of academic impact, for papers by N. Manoj Breakdown of academic impact, for papers by James L. Pipkin Breakdown of academic impact, for papers by Alexander N. Patananan Breakdown of academic impact, for papers by Jessica L. Counihan
Rankless by CCL
2026